FindTrial
Sign In

to assess the impact of COVID-19 pandemic on the delivery of radiation therapy in delhi national capital region, india

impact of COVID-19 pandemic on the delivery of radiation therapy in delhi national capital region, india

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/08/027192
Enrollment
500
Registered
2020-08-17
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere

Interventions

None listed

Sponsors

Dr Rashi Agarwal
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Diagnosed with cancer 2. Those who started radiotherapy between Jan 1 st 2020 to May 31 th 2020

Exclusion criteria

Exclusion criteria: Those who started radiotherapy before Jan 1 st 2020 and after May 31 th 2020

Design outcomes

Primary

MeasureTime frame
Percentage change in number of patients starting radiation treatment during this time period We will compare the interval between last scheduled cancer directed treatment (surgery or neoadjuvant chemo) and the start of radiation therapy or interval between date of diagnosis and start of radiation therapy if radiation being first treatment between pre COVID time (Jan 1 st 2020 â?? 22nd March 2020) and during COVID time (23rdMarch 2020- 31 st May 2020).Timepoint: 5 months—

Secondary

MeasureTime frame
Percentage of patients in whom radiation treatment is delayed.Timepoint: 5 months—

Countries

India

Contacts

Public ContactDr Rashi Agrawal

Max Super Speciality Hospital,A Unit of Crosslay Remedies Ltd.

drrashi.ag@gmail.com9813681889

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026